This page contains brief information about dostarlimab-gxly and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Dostarlimab-gxly is approved to treat:
- Endometrial cancer that has come back or has spread and cannot be removed by surgery. It is used in adults whose cancer is mismatch repair deficient (dMMR) and got worse during or after platinum chemotherapy.
Dostarlimab-gxly is also being studied in the treatment of other types of cancer.
More About Dostarlimab-gxly
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Dostarlimab-gxly - Check for trials from NCI's list of cancer clinical trials now accepting patients.